Literature DB >> 19661128

Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study.

Bu B Yeap1, S A Paul Chubb, Zoë Hyde, Konrad Jamrozik, Graeme J Hankey, Leon Flicker, Paul E Norman.   

Abstract

OBJECTIVE: Insulin resistance is associated with metabolic syndrome and type 2 diabetes, representing a risk factor for cardiovascular disease. This relationship may be modulated to some extent by age-related changes in sex hormone status. We examined whether lower testosterone or sex hormone-binding globulin (SHBG) levels in older men are associated with insulin resistance independently of measures of central obesity.
DESIGN: Cross-sectional analysis of 2470 community-dwelling non-diabetic men aged > or = 70 years.
METHODS: Age, body mass index (BMI) and waist circumference were measured. Early morning sera were assayed for total testosterone, SHBG, LH and insulin levels. Free testosterone was calculated using mass action equations, and insulin resistance was assessed using a homeostatic model (HOMA2-IR).
RESULTS: Total testosterone, free testosterone and SHBG declined progressively across increasing quintiles of HOMA2-IR (all P<0.001) and correlated inversely with log HOMA2-IR (r=-0.27, -0.14 and -0.24 respectively, all P<0.001). After adjusting for age, BMI, waist circumference, high-density lipoprotein and triglyceride levels, total testosterone was independently associated with log HOMA2-IR (beta=0.05, P<0.001), while SHBG was not. Serum total testosterone <8 nmol/l was associated with HOMA2-IR in the highest quintile (odds ratio (OR) 1.67, 95% confidence interval (CI) 1.02-2.73) as was total testosterone > or = 8 and <15 nmol/l (OR 1.29, 95% CI 1.03-1.63).
CONCLUSIONS: In older men, lower total testosterone is associated with insulin resistance independently of measures of central obesity. This association is seen with testosterone levels in the low to normal range. Further studies are needed to evaluate interventions that raise testosterone levels in men with reduced insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19661128     DOI: 10.1530/EJE-09-0348

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  31 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

Review 2.  The evaluation and management of testosterone deficiency: the new frontier in urology and men's health.

Authors:  William P Conners; Abraham Morgentaler
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

3.  Testosterone and insulin resistance in the metabolic syndrome and T2DM in men.

Authors:  Preethi M Rao; Daniel M Kelly; T Hugh Jones
Journal:  Nat Rev Endocrinol       Date:  2013-06-25       Impact factor: 43.330

Review 4.  Testosterone deficiency, insulin-resistant obesity and cognitive function.

Authors:  Hiranya Pintana; Nipon Chattipakorn; Siriporn Chattipakorn
Journal:  Metab Brain Dis       Date:  2015-02-24       Impact factor: 3.584

5.  The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.

Authors:  Farid Saad; Louis J Gooren
Journal:  J Obes       Date:  2010-08-10

6.  [Testosterone and the metabolic syndrome].

Authors:  M Schubert; F Jockenhövel
Journal:  Urologe A       Date:  2010-01       Impact factor: 0.639

Review 7.  Benefits and Consequences of Testosterone Replacement Therapy: A Review.

Authors:  Polackwich As; Tadros Nn; Ostrowski Ka; Hedges Jc
Journal:  Eur Endocrinol       Date:  2013-03-15

8.  Can Serum Testosterone Be Used as a Marker of Overall Health?

Authors:  Michael A Mederos; Aaron M Bernie; Jason M Scovell; Ranjith Ramasamy
Journal:  Rev Urol       Date:  2015

9.  Effects of bariatric surgery on male obesity-associated secondary hypogonadism: comparison of laparoscopic gastric bypass with restrictive procedures.

Authors:  Berniza Calderón; Alba Galdón; Alfonso Calañas; Roberto Peromingo; Julio Galindo; Francisca García-Moreno; Gloria Rodriguez-Velasco; Antonia Martín-Hidalgo; Clotilde Vazquez; Héctor F Escobar-Morreale; José I Botella-Carretero
Journal:  Obes Surg       Date:  2014-10       Impact factor: 4.129

Review 10.  Testosterone replacement therapy and cardiovascular risk.

Authors:  Thiago Gagliano-Jucá; Shehzad Basaria
Journal:  Nat Rev Cardiol       Date:  2019-09       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.